Stifel analyst Brian Brophy raised the firm’s price target on Legence (LGN) to $47 from $36 and keeps a Buy rating on the shares. Q3 revenue was above expectations, driven by strength in Data Centers & Technology, notes the analyst, who views the Bowers deal and progress on third-party fabrication sales “quite favorably.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
